Trying to Stay Ahead of Coronavirus Variants, Companies Still Rushing to Develop COVID Drugs

<p>Companies are still in a rush working on drugs that can help treat COVID-19 and stay ahead of new, more transmissible variants that are popping up all over. Monoclonal antibody drugs are administered intravenously making them a little cumbersome, and some are working on new ones that are more accessible and maybe given as a shot. Joseph Walker, reporter at the WSJ, joins us for the race to stay ahead of coronavirus mutations.</p><p> </p> Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>